JPWO2023145486A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2023145486A5
JPWO2023145486A5 JP2023576781A JP2023576781A JPWO2023145486A5 JP WO2023145486 A5 JPWO2023145486 A5 JP WO2023145486A5 JP 2023576781 A JP2023576781 A JP 2023576781A JP 2023576781 A JP2023576781 A JP 2023576781A JP WO2023145486 A5 JPWO2023145486 A5 JP WO2023145486A5
Authority
JP
Japan
Prior art keywords
fesoterodine fumarate
amount
fumarate
fesoterodine
containing formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023576781A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023145486A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2023/000786 external-priority patent/WO2023145486A1/ja
Publication of JPWO2023145486A1 publication Critical patent/JPWO2023145486A1/ja
Publication of JPWO2023145486A5 publication Critical patent/JPWO2023145486A5/ja
Pending legal-status Critical Current

Links

JP2023576781A 2022-01-28 2023-01-13 Pending JPWO2023145486A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022011565 2022-01-28
PCT/JP2023/000786 WO2023145486A1 (ja) 2022-01-28 2023-01-13 フェソテロジンフマル酸塩含有製剤の製造方法

Publications (2)

Publication Number Publication Date
JPWO2023145486A1 JPWO2023145486A1 (https=) 2023-08-03
JPWO2023145486A5 true JPWO2023145486A5 (https=) 2024-06-26

Family

ID=87471342

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023576781A Pending JPWO2023145486A1 (https=) 2022-01-28 2023-01-13

Country Status (3)

Country Link
JP (1) JPWO2023145486A1 (https=)
TW (1) TWI836872B (https=)
WO (1) WO2023145486A1 (https=)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4174300B2 (ja) * 2001-11-13 2008-10-29 壽製薬株式会社 Ｌ−グルタミンおよびアズレンスルホン酸ナトリウムを含有する速崩錠または口腔内崩壊錠並びにその製造方法
RU2283092C2 (ru) * 2002-02-01 2006-09-10 Пфайзер Продактс Инк. Сухие гранулированные композиции азитромицина
JP2004035517A (ja) * 2002-07-08 2004-02-05 Wyeth Lederle Japan Ltd カルバペネム系抗生剤含有経口製剤
TW200733975A (en) * 2005-12-20 2007-09-16 Pfizer Prod Inc Pharmaceutical combination for the treatment of luts
CN101466371B (zh) * 2006-06-09 2011-10-05 施瓦茨制药有限公司 含非索罗定的稳定的药用组合物
EP2508175A1 (en) * 2011-04-08 2012-10-10 LEK Pharmaceuticals d.d. Pharmaceutical composition comprising fesoterodine or a salt or a solvate thereof
US20130236544A1 (en) * 2012-03-08 2013-09-12 Dr. Reddy's Laboratories Ltd. Stable pharmaceutical compositions of fesoterodine
US9629805B2 (en) * 2013-03-07 2017-04-25 Amneal Pharmaceuticals Llc Stabilization of moisture-sensitive drugs
SI3881833T1 (sl) * 2015-06-30 2024-03-29 Genentech, Inc., Tablete s takojšnjim sproščanjem, ki vsebujejo zdravilo in postopek za oblikovanje tablet
JP2018184375A (ja) * 2017-04-27 2018-11-22 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ダビガトランエテキシラート又は医薬的に許容されるその塩を含む錠剤及びその製造方法
WO2019206391A1 (en) * 2018-04-26 2019-10-31 Rontis Hellas S.A. Extended release pharmaceutical composition containing fesoterodine and process for the preparation thereof
EP3875088A4 (en) * 2018-10-31 2021-12-29 FUJIFILM Corporation Package for medical composition containing anti-tumor agent

Similar Documents

Publication Publication Date Title
US4439453A (en) Directly compressible acetaminophen granulation
JP4781489B2 (ja) フェソテロジンを含む安定した医薬組成物
KR19990028693A (ko) 불용성 약물의 방출 조정 배합물
JP6126456B2 (ja) 打錠用顆粒とその製造方法、その打錠用顆粒を用いた口腔内崩壊錠
US7749536B2 (en) Pharmaceutical formulations of aliphatic amine polymers and methods for their manufacture
HUE030376T2 (en) A method of preparing a solid oral dosage form comprising solifenacin and its pharmaceutically acceptable salts
CA2584547C (en) Solid pharmaceutical composition comprising donepezil hydrochloride
RU2377989C2 (ru) Лекарственное средство триметазидина в форме матриксной таблетки с пролонгированным действием и способ его получения
JPWO2023145486A5 (https=)
TWI836872B (zh) 含弗斯特羅定反丁烯二酸鹽製劑的製造方法
CA2832500A1 (en) Pharmaceutical composition comprising fesoterodine
GB2090739A (en) Directly compressible acetaminophen granulation
JP6606287B2 (ja) 口腔内崩壊錠添加用組成物
JP2010189378A (ja) フィルムコーティングされた昇華性成分含有固形製剤
JP2024174574A (ja) ミラベグロン製剤
EP1818048B1 (en) Pharmaceutical formulations of aliphatic amine polymers and methods for their manufacture
CA2355291C (en) A pharmaceutical mixture comprising a profen
AU1006600A (en) Sustained release tablets containing bupropion hydrochloride
KR101135234B1 (ko) 마늘유를 함유하는 경구제형의 제제
TR201820589A2 (tr) Fesoterodi̇n i̇çeren stabi̇l farmasöti̇k bi̇leşi̇m
JP6651638B2 (ja) 口腔内崩壊錠添加用組成物
JP2007131591A (ja) 胃内滞留型徐放性固形製剤
CN1507861A (zh) 一种马来酸曲美布汀片及其制备方法
JP4034472B2 (ja) 低置換度ヒドロキシプロピルセルロース及び固形製剤
WO2023182332A1 (ja) 口腔内崩壊錠用の添加剤組成物